1[1]Robert F, Mattrey J. Ultrasound contrast applications in r adiology. Presented in 4th heart center European symposium on ul trasound contrast imaging. Jan, 1999.
2[2]Fuminori Moriyasu. In vivo behavior of microbubbles observed using harmonic gray scale imaging[C].Presented in 4th heart center European symposium on ultrasound contrast inaging. Jan,1999.
3[3]Hancock J, Dittrich H, Jewitt DE, et al. Evaluation of myocardial, hepati c, and renal perfusion in a variety of clinical conditions using an intravenous ul trasound contrast agent (Optison) and second harmonic imaging [J]. Heart, 1999 , 81(6):636-641.
4[4]Forsberg F, Liu JB, Chiou HJ, et al. Comparison of fundamental and wideba nd harmonic contrast imaging of liver tumors [J]. Ultrasonics, 2000, 38(3):110- 113.
5[5]Porter TR, Xie F. Improved myocardial contrast with second harmonic trans ie nt ultrasound response imaging in human using intravenous perfluorocarbon-expos ed sonicated dextrose albumin[J]. JACC, 1996, 27(6): 1497-1501.
6[6]Verbeek XA, Ledoux LA, Willigers JM, et al. Experimental investigation of t he pulse inversion technique for imaging ultrasound contrast agents [J]. J Aco ust Soc Am, 2000, 107(4): 2281-2290.
7[7]Schlief R, Bauer A, Mahler M, et al. LOC-imaging with SHU563A in humans -results of a phase I clinical trial[C]. Presented in 2nd heart center European symposium on ultrasound contrast imaging. Jan, 1997.
8[8]Albrecht T, Blomley MJK, Cosgrove DO, et al. Microbubble enhanced dynamic hepatic Doppler venogaphy a promising novel technique for the noninvasive diagnosis of liver cirrhosis[C]. Presented in 3rd heart center European symposium on ultrasound contrast imaging. Jan, 1998.
9[9]Michelle L, Therese M. The potential role of ultrasound contrast agents I n the liver [J]. Applied Radiology, 1997, 26(1):13-18.
10[10]Plew J, Sanki J, Young N, et al. Early experience in the use of Levovist u ltrasound contrast in the evaluation of liver masses[J]. Australia Radiol, 200 0, 44(1):28-31.
9Quaiae E,Calliadaf F Bertolottom M,et al.Charactertionization of focal liver lesions with contrast-speeffie US modes and a sulfur hexafluoride-filled mierobubble contrast agent:diagnostic performance and confidenle[J].Radiology,2004,232(2):420-430.
10Faccioli N, D'Onofrio M, Malago R, et al. Resectable pancreatic adenocarcinoma: iepiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas, 2008,37(3) :265-268.
